Xyall is on a mission to optimize molecular diagnostic test results for cancer patients by delivering technologies that enable accurate and efficient selection of tumor samples.
Selecting high quality tissue samples for oncology molecular diagnostic testing is a labor-intensive, manual process, with limitations in precision and a potential risk of error. Xyall provides a fully automated solution for tissue dissection.